1. Pink Sheet
  2. >>Geography
  3. >>Asia
  4. >>Japan

Ricks Renews PhRMA Call For Comprehensive Japan Policy Dialog

'Transparency And Predictability' Needed

 
• By Ian Haydock

US research-based group again calls for a comprehensive dialog with all healthcare system stakeholders in Japan to address what it sees as "harmful" policies that have reduced the country's support for innovation and attractiveness as a market for drug development amid the rapid rise of some regional neighbors.

japan health
US industry group calls for comprehensive Japan policy dialog • Source: Alamy

The US research-based pharma industry is continuing to call for broad reforms to ensure the sustainability of Japan’s healthcare ecosystem, which it sees as essential to rebuilding the country’s attractiveness as a location for innovation and new drug development.

As to what the most appropriate forum for such a dialog would be, Pharmaceutical Research and Manufacturers of America (PhRMA)...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Japan

More from Asia

To Compete With China, US FDA Must Deregulate Early Gene Therapy Studies, CAR-T Inventor Says

 
• By Sarah Karlin-Smith

FDA regulation was painted as an obstacle to US dominance in the cell and gene therapy space even as panelists at an agency event praised the Office of Therapeutic Products' track record under Nicole Verdun.

New Era Begins In Korea: Policy Predictions For Biopharma

 
• By Jung Won Shin

As South Korea's new president immediately gets to work on setting initial policies, essential drug supplies, R&D incentives and AI-driven digital healthcare are among the key topics in focus.

Australia Looks To Modernize Human Tissue Laws, Improving Access For Researchers

 
• By Eliza Slawther

Australia is reviewing its human tissue laws for the first time in almost 50 years, and is hoping to reduce barriers to access for scientific researchers, for instance by addressing issues with access to cell lines for developing drugs.